Jim Mullen, Editas Medicine

Ex-Bio­gen CEO Jim Mullen steps back to the helm of a biotech, and once again he has a crit­i­cal chal­lenge to con­front

A decade af­ter he was pushed out of the top post at Bio­gen by a gang of ac­tivists, Jim Mullen is step­ping back up to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.